Increased Expression of TGF-β1 in Correlation with Liver Fibrosis during Echinococcus granulosus Infection in Mice
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
To investigate the potential role of transforming growth factor (TGF)-β1 in liver fibrosis during Echinococcus granulosus infection, 96 BALB/c mice were randomly divided into 2 groups, experimental group infected by intraperitoneal injection with a metacestode suspension and control group given sterile physiological saline. The liver and blood samples were collected at days 2, 8, 30, 90, 180, and 270 post infection (PI), and the expression of TGF-β1 mRNA and protein was determined by real-time quantitative RT-PCR and ELISA, respectively. We also evaluated the pathological changes in the liver during the infection using hematoxylin and eosin (H-E) and Masson staining of the liver sections. Pathological analysis of H-E stained infected liver sections revealed liver cell edema, bile duct proliferation, and structural damages of the liver as evidenced by not clearly visible lobular architecture of the infected liver, degeneration of liver cell vacuoles, and infiltration of lymphocytes at late stages of infection. The liver tissue sections from control mice remained normal. Masson staining showed worsening of liver fibrosis at the end stages of the infection. The levels of TGF-β1 did not show significant changes at the early stages of infection, but there were significant increases in the levels of TGF-β1 at the middle and late stages of infection (P<0.05). RT-PCR results showed that, when compared with the control group, TGF-β1 mRNA was low and comparable with that in control mice at the early stages of infection, and that it was significantly increased at day 30 PI and remained at high levels until day 270 PI (P<0.05). The results of this study suggested that increased expression of TGF-β1 during E. granulosus infection may play a significant role in liver fibrosis associated with E. granulosus infection.
Abstract
To investigate the potential role of transforming growth factor (TGF)-β1 in liver fibrosis during Echinococcus granulosus infection, 96 BALB/c mice were randomly divided into 2 groups, experimental group infected by intraperitoneal injection with a metacestode suspension and control group given sterile physiological saline. The liver and blood samples were collected at days 2, 8, 30, 90, 180, and 270 post infection (PI), and the expression of TGF-β1 mRNA and protein was determined by real-time quantitative RT-PCR and ELISA, respectively. We also evaluated the pathological changes in the liver during the infection using hematoxylin and eosin (H-E) and Masson staining of the liver sections. Pathological analysis of H-E stained infected liver sections revealed liver cell edema, bile duct proliferation, and structural damages of the liver as evidenced by not clearly visible lobular architecture of the infected liver, degeneration of liver cell vacuoles, and infiltration of lymphocytes at late stages of infection. The liver tissue sections from control mice remained normal. Masson staining showed worsening of liver fibrosis at the end stages of the infection. The levels of TGF-β1 did not show significant changes at the early stages of infection, but there were significant increases in the levels of TGF-β1 at the middle and late stages of infection (P<0.05). RT-PCR results showed that, when compared with the control group, TGF-β1 mRNA was low and comparable with that in control mice at the early stages of infection, and that it was significantly increased at day 30 PI and remained at high levels until day 270 PI (P<0.05). The results of this study suggested that increased expression of TGF-β1 during E. granulosus infection may play a significant role in liver fibrosis associated with E. granulosus infection.
참고문헌 (21)
- Wen H, "The echinococcosis learning tutorial. Xinjiang, China Vol. 7", pp.57~63 (2009), Xinjiang People's Publishing House
- Leggatt GR, "Sequence homology between two immunodiagnostic fusion proteins from Echinococcus multilocularis", Int J Parasitol, 22, pp.831~833 (1992)
- Ito A, "Introduction of ongoing research projects on echinococcosis at Asahikawa Medical College and some comments on the surveillance, prevention and control of alveolar echinococcosis in Japan", Hokkaido Igaku Zasshi, 76, pp.3~8 (2001)
- Friedman SL, "Evolving challenges in hepatic fibrosis", Nat Rev Gastroenterol Hepatol, 7, pp.425~436 (2010)
- Gorelik L, "Transforming growth factor-beta in T-cell biology", Nat Rev Immunol, 2, pp.46~53 (2002)
- Ray K, "Liver: hepatic stellate cells hold the key to liver fibrosis", Nat Rev Gastroenterol Hepatol, 11, pp.74~ (2014)
- Kocabayoglu P, "Cellular basis of hepatic fibrosis and its role in inflammation and cancer", Front Biosci (Schol Ed), 5, pp.217~230 (2013)
- Tsolaki E, "Hematopoietic stem cells and liver regeneration: differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury", Blood Cells Mol Dis, 53, pp.124~132 (2014)
- Hu X, "Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β", Smad signaling, 2014, pp.29, 1284~1291
- Zhai W, "The diagnosis of chronic hepatitis, grading and staging", Chinese Digest Magazine, 5, pp.277~ (1996)
- Gressner OA, "Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?", J Gastroenterol Hepatol, 23, pp.1024~1035 (2008)
- Friedman SL, "Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver", Physiol Rev, 88, pp.125~172 (2008)
- Bataller R, "Liver fibrosis", J Clin Invest, 115, pp.209~218 (2005)
- Le Bousse-Kerdilès MC, "Cellular and molecular mechanisms underlying bone marrow and liver fibrosis: a review", Eur Cytokine Netw, 19, pp.69~80 (2008)
- Baker RJ, "Mastery of Surgery", pp.1082~1099 (2001), Lippincott Williams and Willkins Inc
- Wilson MS, "Immunopathology of schistosomiasis", Immunol Cell Biol, 85, pp.148~154 (2007)
- Dong C, "Th17 cells in development: an updated view of their molecular identity and genetic programming", Nat Rev Immunol, 8, pp.337~348 (2008)
- Martin-Martin N, "TGF-β1 mediates sirolimus and cyclosporine A-induced alteration of barrier function in renal epithelial cells via a noncanonical ERK 1", 2 signaling pathway, 2011, pp.301, 1281~1292
- Herbert DR, "IL-10 and TGF-β redundantly protect against severe liver injury and mortality during acute schistosomiasis", J Immunol, 181, pp.7214~7220 (2008)
- Liu X, "Therapeutic strategies against TGF-β signaling pathway in hepatic fibrosis", Liver Int, 26, pp.8~22 (2006)
- Breitkopf K, "Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture", Hepatology, 33, pp.387~396 (2001)